603259 药明康德
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额8,379,09213,386,91210,616,0304,589,2893,973,728
投资活动产生之现金流量净额(3,194,217)(7,560,534)(9,690,286)(4,838,953)(8,775,768)
筹资活动产生之现金流量净额(5,904,884)(3,941,384)(1,277,808)(1,723,914)9,888,047
汇率变动对现金及现金等价物的影响(9,427)132,140160,633(79,143)(81,243)
现金及现金等价物净增加/(减少)(729,436)2,017,135(191,432)(2,052,721)5,004,764
期初现金及现金等价物余额10,001,0397,983,9048,175,33610,228,0575,223,293
期末现金及现金等价物余额9,271,60310,001,0397,983,9048,175,33610,228,057